Protective effect of silibinin against liver oxidative stress in Psammomys obesus, model of insulin resistance and Type 2 diabetes

被引：0
|
作者：
Bouderba, S. [1 ]
机构：
[1] USTHB, Algiers, Algeria
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2013年 / 27卷
关键词：
Psammomys obesus; silibinin; insulin resistance; diabetes; oxidative stress;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 50 条
  • [1] Intestinal tepid transport in Psammomys obesus, a model of insulin resistance and type 2 diabetes
    Levy, EH
    Zoltowska, M
    Marcil, V
    Ziv, E
    Delvin, E
    Kalman, R
    Garofalo, C
    Lambert, M
    Seidman, E
    GASTROENTEROLOGY, 2003, 124 (04) : A432 - A432
  • [2] Intestinal and hepatic cholesterol transporters in Psammomys Obesus, a model of insulin resistance and type 2 diabetes
    Lalonde, Genevieve
    Devin, Edgard
    Elchebly, Mounib
    Sane, Alain Theophile
    Lambert, Marie
    Garofalo, Carole
    Ziv, Ehud
    Levy, Emile
    FASEB JOURNAL, 2008, 22
  • [3] Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes
    Bouderba, Saida
    Sanchez-Martin, Carlos
    Villanueva, Gloria R.
    Detaille, Dominique
    Koceir, E. Ahmed
    JOURNAL OF DIABETES, 2014, 6 (02) : 184 - 192
  • [4] Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes
    Ziv, E
    Shafrir, E
    Kalman, R
    Galer, S
    Bar-On, H
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (12): : 1549 - 1554
  • [5] Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus -: A model of insulin resistance and type 2 diabetes
    Zoltowska, M
    Ziv, E
    Delvin, E
    Sinnett, D
    Kalman, R
    Garofalo, C
    Seidman, E
    Levy, E
    DIABETES, 2003, 52 (10) : 2539 - 2545
  • [6] Prevalence of insulin resistance in relation to age in psammomys obesus, a model of nutritonally induced type 2 diabetes.
    Ziv, E
    Shafrir, E
    Kalman, R
    Galer, S
    Bar-On, H
    DIABETOLOGIA, 1999, 42 : A176 - A176
  • [7] Liraglutide reverses diabetes in Psammomys obesus, a model of type 2 diabetes
    Bodvarsdottir, TB
    Jensen-Holm, HB
    Joergensen, MS
    Buccholz, T
    Knudsen, LB
    DIABETES, 2005, 54 : A123 - A123
  • [8] β-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes
    Leibowitz, G
    Yuli, M
    Donath, MY
    Nesher, R
    Melloul, D
    Cerasi, E
    Gross, DJ
    Kaiser, N
    DIABETES, 2001, 50 : S113 - S117
  • [9] Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus
    Vedtofte, Louise
    Bodvarsdottir, Thora B.
    Gotfredsen, Carsten F.
    Karlsen, Allan E.
    Knudsen, Lotte B.
    Heller, R. Scott
    REGULATORY PEPTIDES, 2010, 160 (1-3) : 106 - 114
  • [10] Psammomys obesus, a model for environment-gene interactions in type 2 diabetes
    Kaiser, N
    Nesher, R
    Donath, MY
    Fraenkel, M
    Behar, V
    Magnan, C
    Ktorza, A
    Cerasi, E
    Leibowitz, G
    DIABETES, 2005, 54 : S137 - S144
12345